Both groups had improved left ventricular function , but change in left ventricular ejection fraction was lower in patients treated with G-CSF than in those who received placebo ( @ -LSB- @ % CI @-@ @ -RSB- percentage points v. @ -LSB- @ % CI @-@ @ -RSB- percentage points ) .